Buy ARA290 2mg Australia
This product is intended for research and medical purposes only, to be only used by trained professionals.
ARA-290 is a small peptide derived from the erythropoietin helix beta domain (EPO). EPO has long been known to have effects other than stimulating the production of red blood cells in the bone marrow.
In diabetic neuropathy, the glycoprotein, a protein made in the kidney, has been shown to stimulate blood vessel growth, promote cell survival, and alter blood pressure.
As an EPO neuroprotectant and pain reliever, ARA-290 does not stimulate the production of red blood cells.
For diabetes and autoimmunity, ARA-290 could be tested, according to studies. In addition, the peptide’s ability to alleviate neuropathic pain is currently being studied.
It is also being studied as a possible wound-healing stimulant, an immune-modulator, and potential systemic lupus erythematosus (lupus or SLE) treatment.
Molecular Formula: C51H84N16O21
Storage: Lyophilized peptides stored below -18°C.
Research use only. Not for human or animal consumption!
Disclaimer: We do not supply peptides to Any individual under the age of 18. You must be a licensed and qualified healthcare practitioner. Our team of dedicated professionals are committed to providing an extensive range of products used ONLY FOR medical research by responsible trained and professional individuals. All products listed on this website (https://direct-peptides.com) and provided through Direct Peptides are intended for medical research purposes only. Direct Peptides does not encourage or promote the use of any of these products in a personal capacity (i.e. human consumption), nor are the products intended as a drug, stimulant or for use in any food products.